CrushSCI.com
112.4Average days
89Median days
3Fastest days
370Longest days
2062025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

5 days

Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

Authors
Norio Akuta; Tomomi Kogiso; Kenichi Ikejima; Motoyuki Otsuka; Takumi Kawaguchi; Miwa Kawanaka; Hirokazu Takahashi; Nobuharu Tamaki; Hayato Nakagawa; Hayato Hikita; Hideki Fujii; Kanji Yamaguchi; Masato Yoneda; Kazuyoshi Kon; Akira Uchiyama; Yuya Seko; Sadatsugu Sakane; Ryuta Shigefuku; Naoto Fujiwara; Michihiro Iwaki; Takashi Kobayashi; Takuya Adachi; Yasuto Takeuchi; Tsubasa Tsutsumi; Dan Nakano; Kaoru Shibayama; Noriyo Urata; Hisamitsu Miyaaki; Hidekatsu Kuroda; Masahiro Koseki; Hirohito Sone; Yasuhiro Matsubayashi; Keisuke Kakisaka; Atsushi Takai; Kazuo Notsumata; Masataka Seike; Yoshiyuki Takei; Yoshifumi Takeyama; Susumu Eguchi; Sumio Watanabe; Hajime Isomoto; Hiroshi Yotsuyanagi; Takao Itoi; Tetsuo Takehara; Satoshi MochidaShow moreShow less
Affiliations
1. Guidelines Committee for Creating and Evaluating the “Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction‐Associated Steatotic Liver Disease 2026 (3rd Edition)” The Japanese Society of Gastroenterology/The Japan Society of Hepatology Tokyo Japan; 2. Department of Hepatology Toranomon Hospital 2‐2‐2 Tokyo Japan; 3. Department of Internal Medicine Institute of Gastroenterology, Tokyo Women’s Medical University 8‐1 Tokyo Japan; 4. The Japan Society of Hepatology Tokyo JapanShow moreShow less
Source PDF DOI Publisher page
28 days

Ablation‐Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma

Authors
Kazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi KumadaShow moreShow less
Affiliations
1. Department of Gastroenterology Okayama City Hospital Okayama Japan; 2. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan; 3. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan; 4. Department of Internal Medicine Division of Gastroenterology Kobe University Graduate School of Medicine Kobe Japan; 5. Center for Gastroenterology Teine Keijinkai Hospital Sapporo Japan; 6. Department of Gastroenterology Asahi General Hospital Asahi Japan; 7. Department of Hepatology Kagawa Prefectural Central Hospital Takamatsu Japan; 8. Department of Internal Medicine Niigata Cancer Center Hospital Niigata Japan; 9. Department of Gastroenterology Saiseikai Niigata Hospital Niigata Japan; 10. Department of Gastroenterology Gunma Saiseikai Maebashi Hospital Maebashi Japan; 11. Department of Clinical Research NHO Takasaki General Medical Center Takasaki Japan; 12. Department of Gastroenterology NHO Takasaki General Medical Center Takasaki Japan; 13. Department of Gastroenterology Kakogawa City Hospital Kakogawa Japan; 14. Department of Gastroenterology Hyogo Prefectural Harima‐Himeji General Medical Center Himeji Japan; 15. Department of Hepatology Wakayama Rosai Hospital Wakayama Japan; 16. Department of Gastroenterology Takarazuka City Hospital Takarazuka Hyogo Japan; 17. Department of Gastroenterology Hanwa Memorial Hospital Osaka Japan; 18. Department of Gastroenterology and Hepatology Faculty of Medicine Kindai University Osaka Japan; 19. Department of Nursing Gifu Kyoritsu University Ogaki JapanShow moreShow less
Source PDF DOI Publisher page
128 days

Widespread Muscle Loss in Autoimmune Hepatitis and Its Adverse Prognostic Impact

Authors
Tomoko Tadokoro; Asahiro Morishita; Takushi Manabe; Hiroki Tai; Rie Yano; Mai Nakahara; Kyoko Oura; Koji Fujita; Shima Mimura; Joji Tani; Hideki KobaraShow moreShow less
Affiliations
1. Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kagawa Japan; 2. Department of Gastroenterology and Hepatology Takamatsu Red Cross Hospital Takamatsu JapanShow moreShow less
Source PDF DOI Publisher page
50 days

From Genomic Instability to Epigenetic Signatures: The Evolving Landscape of Circulating Cell‐free DNA in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Authors
Wei‐Yue Lim; Rosmawati Mohamed; Yuh‐Fen Pung; Shamsul Mohd ZainShow moreShow less
Affiliations
1. Department of Pharmacology Faculty of Medicine Universiti Malaya Kuala Lumpur Malaysia; 2. Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia; 3. Division of Biomedical Science School of Pharmacy University of Nottingham Malaysia Semenyih Selangor MalaysiaShow moreShow less
Source PDF DOI Publisher page
101 days

Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan

Authors
Yutaka Handa; Ethan Yichen Lee; Yasuhito TanakaShow moreShow less
Affiliations
1. Specialty Care Medical Affairs, GSK Tokyo Japan; 2. Department of Gastroenterology and Hepatology, Faculty of Life Sciences Kumamoto University Kumamoto JapanShow moreShow less
Source PDF DOI Publisher page
87 days

Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Authors
Fujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real‐life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) GroupShow moreShow less
Affiliations
1. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan; 2. Division of Gastroenterology Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan; 3. Department of Internal Medicine Japanese Red Cross Himeji Hospital Himeji Japan; 4. Department of Gastroenterology and Metabology Ehime University Graduate School of Medicine Toon Japan; 5. Department of Gastroenterology Okayama City Hospital Okayama Japan; 6. Department of Gastroenterology and Neurology Kagawa University Kagawa Japan; 7. Division of Gastroenterology and Hepatology Department of Internal Medicine Nippon Medical School Tokyo Japan; 8. Department of Hepatology Kagawa Prefectural Central Hospital Takamatsu Japan; 9. Department of Gastroenterology Asahi General Hospital Asahi Japan; 10. Department of Gastroenterology Hyogo Medical University Nishinomiya Japan; 11. Center for Gastroenterology Teine Keijinkai Hospital Sapporo Japan; 12. Department of Gastroenterology Saiseikai Niigata Hospital Niigata Japan; 13. Department of Gastroenterology Toyama University Hospital Toyama Japan; 14. Department of Gastroenterology Takarazuka City Hospital Hyogo Japan; 15. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan; 16. Department of Gastroenterology Japanese Red Cross Takamatsu Hospital Takamatsu Japan; 17. Department of Gastroenterology Gunma Saiseikai Maebashi Hospital Maebashi Japan; 18. Department of Clinical Research NHO Takasaki General Medical Center Takasaki Japan; 19. Hepatology Division Department of Internal Medicine II Hamamatsu University School of Medicine Hamamatsu Japan; 20. Department of Gastroenterology NHO Takasaki General Medical Center Takasaki Japan; 21. Department of Hepatobiliary Surgery Kansai Medical University Hirakata Japan; 22. Department of Gastroenterology Hyogo Prefectural Harima‐Himeji General Medical Center Himeji Japan; 23. Department of Gastroenterology Kakogawa Central City Hospital Kakogawa Japan; 24. Division of Gastroenterology and Hepatology Department of Internal Medicine Iwate Medical University Iwate Japan; 25. Department of Gastroenterology Hanwa Memorial Hospital Osaka Japan; 26. Department of Gastroenterology Osaka Medical and Pharmaceutical University Osaka Japan; 27. Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Osaka Japan; 28. Center for Liver‐ Biliary‐Pancreatic Disease Matsuyama Red Cross Hospital Matsuyama Ehime Japan; 29. Department of Hepatology Wakayama Rosai Hospital Wakayama Japan; 30. Division of Hepato‐Biliary‐Pancreatic Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan; 31. Department of Gastroenterology Kobe Asahi Hospital Kobe Japan; 32. Gifu Kyoritsu University Ogaki Japan; 33. Department of Epidemiology, Infectious Disease Control, and Prevention Hiroshima University Institute of Biomedical and Health Sciences Hiroshima JapanShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.